We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference

By LabMedica International staff writers
Posted on 05 Feb 2018
MEDLAB Middle East, held a week after Arab Health, continued to be the largest attended laboratory and IVD exhibition and conference in the world. More...
Held from February 5-8, 2018, the annual laboratory meeting saw its second year as a stand-alone show and welcomed over 600 exhibitors and more than 25,000 attendees from 129+ countries.
 
MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. As the largest attended laboratory expo worldwide, MEDLAB stems from 15 years of growth alongside the MENA region's largest healthcare gathering, Arab Health.
 
MEDLAB Middle East held in Dubai, UAE, continued to expand in 2018 with the addition of two new halls and the capacity to showcase thousands of new products, equipment and services by the main players in the industry. Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market.
 
At the heart of MEDLAB laboratory conference and exhibition lies the CME-accredited Congress featuring 17 CME-accredited conference tracks. Supported by the Cleveland Clinic, the MEDLAB conferences provide professionals with high-level CME credits. The MEDLAB Conferences cover a diverse range of subjects relating to laboratory management, microbiology, immunology, hematology, clinical chemistry and molecular diagnostics. With over 6,500 conference delegates in attendance from all over the world, the MEDLAB Congress is the ideal platform to come together and discover innovations in medical laboratory testing. MEDLAB Congress 2018 introduced new clinical tracks designed to enhance collaboration between laboratory professionals and clinicians. This will aid in accurate interpretation, quick reporting and diagnosis, therefore strengthening the laboratory’s ability to provide clinical decisions and improve the overall quality of service and care. 
 
This year’s MEDLAB Middle East also featured the Obs-Gyne Exhibition, which provided a platform for over 2,500 obstetricians, gynecologists, fertility specialists and family physicians to gather alongside 60+ of the industry's leading manufacturers to meet, exchange knowledge, share best practices and ultimately improve the level of patient care provided. Some of the key topics of discussion at the Obs-Gyne Exhibition were postpartum hemorrhage, androgen disorders in adolescents, psychological and sexual aspects in female genital cancer, early prediction and prevention of pre-eclampsia, obesity in pregnancy, treatment options for infertile women with uterine fibroids, and monitoring and delivery of the growth of restricted fetus.
 
The Poster Zone at the event displayed the latest research from laboratorians worldwide, promoting knowledge sharing and networking amongst MEDLAB’s delegates, who discussed the latest research, findings and developments within the industry. The Workshop Zone featured workshops hosted by leading laboratory and diagnostic companies who provided a hands-on approach towards utilizing the latest testing methods, findings and technology. MEDLAB Middle East also welcomed dealers and distributors from across the region as well as representatives from hospitals, consultancies and governments who took the opportunity to meet, do business with exhibitors and learn from all professionals within the healthcare and medical laboratory marketplace. 
 

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Automatic CLIA Analyzer
Shine i6000
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.